MC
DVAX

Maverick Capital’s Dynavax Technologies DVAX Stock Holding History

Maverick Capital’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9,168
Closed -$176K – 411
2021
Q3 		$176K Buy
+9,168
New +$122K ﹤0.01% 540

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Maverick Capital's DVAX Position: Q4 2021 in Review

Maverick Capital sold out of Dynavax Technologies (DVAX) in Q4 2021, closing a stake of 9,168 shares — an estimated $176K sold.

Maverick Capital first reported a position in DVAX in Q3 2021 and held it in 1 quarter. The position peaked at $176K in Q3 2021. 200 funds tracked by Wall St. Rank hold DVAX as of Q4 2021.

  • Maverick Capital reported no remaining Dynavax Technologies position as of Q4 2021 after selling out during the quarter.
  • Maverick Capital sold 9,168 Dynavax Technologies shares in Q4 2021, an estimated $176K.
  • Maverick Capital first reported a position in Dynavax Technologies in Q3 2021 and held it in 1 quarter.
  • Maverick Capital's Dynavax Technologies position peaked at $176K in Q3 2021.
  • 200 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2021.

Based on Maverick Capital's 13F filing for Q4 2021, filed 14 Feb 2022.